Role of acetylation in doxorubicin-induced cardiotoxicity

doi:10.1016/j.redox.2021.102089

Paper

DOI: 10.1016/j.redox.2021.102089

Role of acetylation in doxorubicin-induced cardiotoxicity

Published Jul 31, 2021 · Daisong Li, Yanyan Yang, Shizhong Wang

Redox Biology

Q1 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Highly Cited

Study Snapshot

Acetylation plays a crucial role in doxorubicin-induced cardiotoxicity, and understanding its role could improve treatment outcomes in cancer and cardiovascular diseases.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Full text analysis coming soon...

References

DOI: 10.3389/fcell.2021.675465

Mitochondrial Protein Translation: Emerging Roles and Clinical Significance in Disease

Mitochondrial protein translation abnormalities are associated with various diseases, including cancer, cardiovascular, and nervous system diseases, and understanding their regulation may help develop new treatments.

2021·69citations·Fei Wang et al.·Frontiers in Cell and Developmental Biology

Frontiers in Cell and Developmental Biology

DOI: 10.1016/j.ygeno.2021.06.039

Identification of transfer RNA-derived fragments and their potential roles in aortic dissection.

TRFs/tiRNAs dysregulated in aortic dissection tissues may serve as promising biomarkers or therapeutic targets for aortic dissection.

2021·20citations·Xiuxiu Fu et al.·Genomics

Genomics

DOI: 10.1111/jcmm.16719

Expression profiles and potential roles of transfer RNA‐derived small RNAs in atherosclerosis

TRF-Gly-GCC may be a promising target for suppressing abnormal vessel functions, potentially preventing atherosclerosis progression.

2021·30citations·Xiangqin He et al.·Journal of Cellular and Molecular Medicine

Journal of Cellular and Molecular Medicine

DOI: 10.1002/admi.202100229

Aligned Electrospun PLLA/Graphene Microfibers with Nanotopographical Surface Modulate the Mitochondrial Responses of Vascular Smooth Muscle Cells

Aligned electrospun PLLA/graphene microfibers with nanoporous surface can regulate mitochondrial responses in vascular smooth muscle cells, offering potential therapeutic applications.

2021·11citations·Min Li et al.·Advanced Materials Interfaces

Advanced Materials Interfaces

DOI: 10.1007/s12012-020-09620-3

MiR-200a-3p Aggravates DOX-Induced Cardiotoxicity by Targeting PEG3 Through SIRT1/NF-κB Signal Pathway

MiR-200a-3p exacerbates DOX-induced cardiotoxicity by targeting PEG3 through the SIRT1/NF-B signal pathway, offering potential clues for treating DOX-induced cardiotoxicity.

2021·18citations·Qinghua Fu et al.·Cardiovascular Toxicology

Cardiovascular Toxicology

Citations

DOI: 10.1371/journal.pone.0319067

Astragalus polyphenols attenuates doxorubicin-induced cardiotoxicity by activating the PI3K/AKT/NRF2 pathway

Astragalus polyphenols show potential as a therapeutic agent to alleviate doxorubicin-induced cardiotoxicity by regulating the PI3K/AKT/NRF2 pathway and preserving mitochondrial function.

2025·0citations·Xueyang Bai et al.·PLOS One

PLOS One

DOI: 10.1007/s12012-024-09952-4

Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy-Differences in Cardiotoxicity.

Liposomal Doxorubicin (L-DOX) is an effective alternative to conventional Doxorubicin treatment with greatly reduced cardiotoxicity, maintaining efficacy comparable to conventional Doxorubicin.

2025·0citations·B. Buchalska et al.·Cardiovascular toxicology

Cardiovascular toxicology

DOI: 10.1016/j.freeradbiomed.2025.01.001

Targeted Mitochondrial Function for Cardiac Fibrosis: an Epigenetic Perspective.

Targeted mitochondrial therapy aims to inhibit cardiac fibroblast proliferation or protect cardiomyocytes from damage by enhancing mitochondrial function, but current research on epigenetic treatments remains limited.

2025·0citations·Peng Liu et al.·Free radical biology & medicine

Free radical biology & medicine

DOI: 10.1016/j.semcancer.2025.01.004

The Dual Function of Autophagy in Doxorubicin-induced Cardiotoxicity: Mechanism and Natural products.

Autophagy plays a critical role in Doxorubicin-induced cardiotoxicity, and autophagy intervention may be a potential therapeutic strategy.

2025·0citations·N. Tan et al.·Seminars in cancer biology

Seminars in cancer biology

DOI: 10.1097/MD.0000000000040287

Shexiang Baoxin Pills alleviate doxorubicin-induced cardiotoxicity via the reactive oxygen species-mediated AKT/Bcl-2 pathway

Shexiang Baoxin Pills alleviate doxorubicin-induced cardiotoxicity by activating the ROS-mediated AKT/Bcl-2 signaling pathway.

2024·0citations·Shudan Wang et al.·Medicine

Medicine

DOI: 10.1016/j.jatmed.2024.12.001

The regulatory role of dexmedetomidine in NLRP3 inflammasome-related organ protection

Dexmedetomidine may protect organs during surgery by inhibiting NLRP3 inflammasome activation, potentially leading to improved patient outcomes.

2024·0citations·Xiang Wang et al.·Journal of Anesthesia and Translational Medicine

Journal of Anesthesia and Translational Medicine